A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma

Project: Research

Project Details

StatusActive
Effective start/end date4/03/213/03/26

Keywords

  • phase 3 study
  • lymphoma
  • treatment safety
  • treatment efficacy